372 related articles for article (PubMed ID: 18211953)
21. Comparative genomic hybridization analysis of newly established retinoblastoma cell lines of adherent growth compared with Y79 of nonadherent growth.
Kim JH; Kim JH; Yu YS; Kim DH; Kim YK; Kim KW
J Pediatr Hematol Oncol; 2008 Aug; 30(8):571-4. PubMed ID: 18799932
[TBL] [Abstract][Full Text] [Related]
22. Developmental stage-specific proliferation and retinoblastoma genesis in RB-deficient human but not mouse cone precursors.
Singh HP; Wang S; Stachelek K; Lee S; Reid MW; Thornton ME; Craft CM; Grubbs BH; Cobrinik D
Proc Natl Acad Sci U S A; 2018 Oct; 115(40):E9391-E9400. PubMed ID: 30213853
[TBL] [Abstract][Full Text] [Related]
23. The retinoblastoma tumour suppressor in development and cancer.
Classon M; Harlow E
Nat Rev Cancer; 2002 Dec; 2(12):910-7. PubMed ID: 12459729
[TBL] [Abstract][Full Text] [Related]
24. Increasing genomic instability during premalignant neoplastic progression revealed through high resolution array-CGH.
Lai LA; Paulson TG; Li X; Sanchez CA; Maley C; Odze RD; Reid BJ; Rabinovitch PS
Genes Chromosomes Cancer; 2007 Jun; 46(6):532-42. PubMed ID: 17330261
[TBL] [Abstract][Full Text] [Related]
25. The nuclear oncoproteins: RB and p53.
Cowell JK
Semin Cancer Biol; 1990 Dec; 1(6):437-46. PubMed ID: 2151736
[TBL] [Abstract][Full Text] [Related]
26. Novel p53/p130 axis in bladder tumors.
Mudryj M; Reay E; Beckett L; Dandekar S; deVere White R; Gandour-Edwards R
Urology; 2007 Sep; 70(3):608-12. PubMed ID: 17905135
[TBL] [Abstract][Full Text] [Related]
27. Retinoblastoma: from disease to discovery.
Madhavan J; Ganesh A; Kumaramanickavel G
Ophthalmic Res; 2008; 40(5):221-6. PubMed ID: 18446017
[TBL] [Abstract][Full Text] [Related]
28. The TAg-RB murine retinoblastoma cell of origin has immunohistochemical features of differentiated Muller glia with progenitor properties.
Pajovic S; Corson TW; Spencer C; Dimaras H; Orlic-Milacic M; Marchong MN; To KH; Thériault B; Auspitz M; Gallie BL
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7618-24. PubMed ID: 21862643
[TBL] [Abstract][Full Text] [Related]
29. Inactivation of the p53 pathway in retinoblastoma.
Laurie NA; Donovan SL; Shih CS; Zhang J; Mills N; Fuller C; Teunisse A; Lam S; Ramos Y; Mohan A; Johnson D; Wilson M; Rodriguez-Galindo C; Quarto M; Francoz S; Mendrysa SM; Guy RK; Marine JC; Jochemsen AG; Dyer MA
Nature; 2006 Nov; 444(7115):61-6. PubMed ID: 17080083
[TBL] [Abstract][Full Text] [Related]
30. Inactivation of the p16 cyclin-dependent kinase inhibitor in high-grade canine non-Hodgkin's T-cell lymphoma.
Fosmire SP; Thomas R; Jubala CM; Wojcieszyn JW; Valli VE; Getzy DM; Smith TL; Gardner LA; Ritt MG; Bell JS; Freeman KP; Greenfield BE; Lana SE; Kisseberth WC; Helfand SC; Cutter GR; Breen M; Modiano JF
Vet Pathol; 2007 Jul; 44(4):467-78. PubMed ID: 17606508
[TBL] [Abstract][Full Text] [Related]
31. The Biology of Retinoblastoma.
Mendoza PR; Grossniklaus HE
Prog Mol Biol Transl Sci; 2015; 134():503-16. PubMed ID: 26310174
[TBL] [Abstract][Full Text] [Related]
32. Expression analysis of 6p22 genomic gain in retinoblastoma.
Orlic M; Spencer CE; Wang L; Gallie BL
Genes Chromosomes Cancer; 2006 Jan; 45(1):72-82. PubMed ID: 16180235
[TBL] [Abstract][Full Text] [Related]
33. The survival gene MED4 explains low penetrance retinoblastoma in patients with large RB1 deletion.
Dehainault C; Garancher A; Castéra L; Cassoux N; Aerts I; Doz F; Desjardins L; Lumbroso L; Montes de Oca R; Almouzni G; Stoppa-Lyonnet D; Pouponnot C; Gauthier-Villars M; Houdayer C
Hum Mol Genet; 2014 Oct; 23(19):5243-50. PubMed ID: 24858910
[TBL] [Abstract][Full Text] [Related]
34. Genomic instability and proliferation/survival pathways in RB1-deficient malignancies.
Pappas L; Xu XL; Abramson DH; Jhanwar SC
Adv Biol Regul; 2017 May; 64():20-32. PubMed ID: 28242412
[TBL] [Abstract][Full Text] [Related]
35. Rb suppresses human cone-precursor-derived retinoblastoma tumours.
Xu XL; Singh HP; Wang L; Qi DL; Poulos BK; Abramson DH; Jhanwar SC; Cobrinik D
Nature; 2014 Oct; 514(7522):385-8. PubMed ID: 25252974
[TBL] [Abstract][Full Text] [Related]
36. RB1 in cancer: different mechanisms of RB1 inactivation and alterations of pRb pathway in tumorigenesis.
Di Fiore R; D'Anneo A; Tesoriere G; Vento R
J Cell Physiol; 2013 Aug; 228(8):1676-87. PubMed ID: 23359405
[TBL] [Abstract][Full Text] [Related]
37. Proteins involved in pRb and p53 pathways are differentially expressed in thin and thick superficial spreading melanomas.
de Sá BC; Fugimori ML; Ribeiro Kde C; Duprat Neto JP; Neves RI; Landman G
Melanoma Res; 2009 Jun; 19(3):135-41. PubMed ID: 19369901
[TBL] [Abstract][Full Text] [Related]
38. [Analysis of the correlation between genetic and immunohistochemical markers (RB1, p16 and p53 gene regultors of a cell cycle) in sporadic mammary gland carcinoma].
Nemtsova MV; Zemliakova VV; Kuznetsova EV; Babenko OV; Zavalishina LE; Andreeva IuIu; Bateva MV; Frank GA; Zaletaev DV
Arkh Patol; 2007; 69(2):3-6. PubMed ID: 17642181
[TBL] [Abstract][Full Text] [Related]
39. Genetic and epigenetic alterations of RB2/p130 tumor suppressor gene in human sporadic retinoblastoma: implications for pathogenesis and therapeutic approach.
Tosi GM; Trimarchi C; Macaluso M; La Sala D; Ciccodicola A; Lazzi S; Massaro-Giordano M; Caporossi A; Giordano A; Cinti C
Oncogene; 2005 Sep; 24(38):5827-36. PubMed ID: 16007224
[TBL] [Abstract][Full Text] [Related]
40. High resolution SNP array profiling identifies variability in retinoblastoma genome stability.
Mol BM; Massink MP; van der Hout AH; Dommering CJ; Zaman JM; Bosscha MI; Kors WA; Meijers-Heijboer HE; Kaspers GJ; Riele Ht; Moll AC; Cloos J; Dorsman JC
Genes Chromosomes Cancer; 2014 Jan; 53(1):1-14. PubMed ID: 24249257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
